

Author: Louz Y.
Publisher: Springer Publishing Company
ISSN: 1965-0817
Source: Journal africain du cancer / African Journal of Cancer, Vol.4, Iss.1, 2012-02, pp. : 62-67
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Les nouveaux médicaments du myélome
Oncologie, Vol. 12, Iss. 5-6, 2010-06 ,pp. :




Entrées et sorties des médicaments hors GHS de la « liste en sus »
By Poivre M.
Oncomagazine, Vol. 4, Iss. 4, 2010-11 ,pp. :




Oncologie, Vol. 9, Iss. 2, 2007-02 ,pp. :